首页> 外文会议>National Biomedical Engineering Meeting >Three Dimensional Bioprinting of Tissue Engineered Artificial Heart Valves by Stereolithography
【24h】

Three Dimensional Bioprinting of Tissue Engineered Artificial Heart Valves by Stereolithography

机译:立体光刻技术对组织工程化人工心脏瓣膜进行三维生物打印

获取原文

摘要

Over the past several decades, there has been an everincreasing demand for organ transplants. There are no significant increase observed in organ donations while the need for organ transplantation is keep increasing. Organ donation emerges as the most feasible solution especially in heart valve diseases. There are two types of artificial heart valves are utilized for heart valve replacement operations. These are mechanical heart valves and bioprosthetic heart valves. However, there are severe intrinsic problems exist for both type of artificial heart valves that are hard to be solved. Due to these reasons, growing or fabricating tissue engineered heart valves using biomaterial scaffolds with a person’s own cells with high biocompatability. The purpose of this study is; fabricating 3D artificial heart valves by stereolithography that has potential to be obtained for heart valve replacements. Stereolithography has proven potential for fabricating 3D models with high structural integrity and strong mechanical properties, yet it has not been evaluated as a bioprinter. In this study, this purpose is aimed to be succeeded.
机译:在过去的几十年中,对器官移植的需求不断增长。没有观察到器官捐赠的显着增加,而器官移植的需求却在不断增加。器官捐赠是最可行的解决方案,尤其是在心脏瓣膜疾病中。有两种类型的人造心脏瓣膜用于心脏瓣膜置换操作。这些是机械心脏瓣膜和生物人工心脏瓣膜。然而,两种人工心脏瓣膜都存在严重的内在问题,这些问题很难解决。由于这些原因,使用具有人体生物相容性高的人体细胞的生物材料支架来生长或制造组织工程性心脏瓣膜。这项研究的目的是:通过立体光刻技术制造3D人工心脏瓣膜,这可能会替代心脏瓣膜。立体光刻技术具有制造高结构完整性和强大机械性能的3D模型的潜力,但尚未被评估为生物打印机。在这项研究中,该目的旨在成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号